Skeletal Muscle Metastases on FDG PET/CT Imaging

BACKGROUNDSkeletal muscle metastases (SMM) are a rare occurrence despite the fact that skeletal muscle comprises more than 50% of total body mass. When present, most are asymptomatic and are often found incidentally on imaging. Several studies have reported isolated cases of patients with SMM. The g...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical nuclear medicine 2012-06, Vol.37 (6), p.575-579
Hauptverfasser: Khandelwal, Alok R, Takalkar, Amol M, Lilien, David L, Ravi, Ajay
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 579
container_issue 6
container_start_page 575
container_title Clinical nuclear medicine
container_volume 37
creator Khandelwal, Alok R
Takalkar, Amol M
Lilien, David L
Ravi, Ajay
description BACKGROUNDSkeletal muscle metastases (SMM) are a rare occurrence despite the fact that skeletal muscle comprises more than 50% of total body mass. When present, most are asymptomatic and are often found incidentally on imaging. Several studies have reported isolated cases of patients with SMM. The goal of our study was to perform a comprehensive retrospective analysis of the incidence, frequency, and source of SMM in patients with malignancies who underwent whole-body FDG PET/CT imaging for the workup for their malignancy. METHODSThe records of 8492 consecutive patients referred for oncologic imaging at our institution during the period from January 2006 to December 2009 were reviewed. Patients who had SMM on FDG PET imaging were further assessed for collaborating evidence on other imaging modalities, pathology from tissue sampling, and follow-up scans. The incidence of SMM in our setting was calculated, and their association with various primary malignancies was also evaluated. RESULTSA total of 73 patients with SMM were identified on PET/CT imaging (incidence, 0.86%). Lung cancer was the most frequent source (25 patients [34%]), followed by gastrointestinal tract malignancies (13 patients [18%]), breast cancer (10 patients [14%]), genitourinary malignancies and lymphoma (6 patients [8%] each), melanoma (5 patients [7%]), and other miscellaneous malignancies (3 patients [4%]). Primary source remained unknown in only 5 patients (7%). Most patients with SMM generally had markedly widespread involvement which led to an unusual appearance on FDG PET/CT imaging. However, since most of these patients had stage IV malignant disease by virtue of visceral metastases elsewhere as well, they were generally not upstaged. CONCLUSIONSOur study confirmed the rare occurrence of SMM. Furthermore, FDG PET/CT can potentially detect unsuspected SMM. Interestingly, in our patient population, lung cancer was found to be the most frequent malignancy metastasizing to the skeletal muscles. Knowledge about the presence and appearance of widespread SMM may aid in appropriate interpretation of FDG PET/CT scans.
doi_str_mv 10.1097/RLU.0b013e3182443e32
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1015464497</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1015464497</sourcerecordid><originalsourceid>FETCH-LOGICAL-p2567-43fd0e7efcfbf0b2e5f25342699df955e4cc74d1e054eab8d00b2375c0fdb6f63</originalsourceid><addsrcrecordid>eNo1j91LAkEUxYco0qz_IGIfe1m98-08hqkJSlH6vOzHHTVnXdvZRfrvndAuBw7n8OPCIeSRQp-C0YPP-aoPGVCOnA6ZEMHZFelSyVUMjJlr0gWueGy0Yh1y5_03AFVUiVvSYUxRQYemS-Brhw6b1EWL1ucOo0UIPgh9VO2jyes0-hgvB6NlNCvT9Xa_vic3NnUeHy7eI6vJeDl6i-fv09noZR4fmFQ6FtwWgBptbjMLGUNpmeSCKWMKa6REkedaFBRBCkyzYQEB4lrmYItMWcV75Pn891BXPy36Jim3Pkfn0j1WrU8oUCmUEEYH9OmCtlmJRXKot2Va_yb_KwMgzsCxcg3WfufaI9bJBlPXbBIIx0GzmAFloEKK_yrNT5ygYvs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1015464497</pqid></control><display><type>article</type><title>Skeletal Muscle Metastases on FDG PET/CT Imaging</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Khandelwal, Alok R ; Takalkar, Amol M ; Lilien, David L ; Ravi, Ajay</creator><creatorcontrib>Khandelwal, Alok R ; Takalkar, Amol M ; Lilien, David L ; Ravi, Ajay</creatorcontrib><description>BACKGROUNDSkeletal muscle metastases (SMM) are a rare occurrence despite the fact that skeletal muscle comprises more than 50% of total body mass. When present, most are asymptomatic and are often found incidentally on imaging. Several studies have reported isolated cases of patients with SMM. The goal of our study was to perform a comprehensive retrospective analysis of the incidence, frequency, and source of SMM in patients with malignancies who underwent whole-body FDG PET/CT imaging for the workup for their malignancy. METHODSThe records of 8492 consecutive patients referred for oncologic imaging at our institution during the period from January 2006 to December 2009 were reviewed. Patients who had SMM on FDG PET imaging were further assessed for collaborating evidence on other imaging modalities, pathology from tissue sampling, and follow-up scans. The incidence of SMM in our setting was calculated, and their association with various primary malignancies was also evaluated. RESULTSA total of 73 patients with SMM were identified on PET/CT imaging (incidence, 0.86%). Lung cancer was the most frequent source (25 patients [34%]), followed by gastrointestinal tract malignancies (13 patients [18%]), breast cancer (10 patients [14%]), genitourinary malignancies and lymphoma (6 patients [8%] each), melanoma (5 patients [7%]), and other miscellaneous malignancies (3 patients [4%]). Primary source remained unknown in only 5 patients (7%). Most patients with SMM generally had markedly widespread involvement which led to an unusual appearance on FDG PET/CT imaging. However, since most of these patients had stage IV malignant disease by virtue of visceral metastases elsewhere as well, they were generally not upstaged. CONCLUSIONSOur study confirmed the rare occurrence of SMM. Furthermore, FDG PET/CT can potentially detect unsuspected SMM. Interestingly, in our patient population, lung cancer was found to be the most frequent malignancy metastasizing to the skeletal muscles. Knowledge about the presence and appearance of widespread SMM may aid in appropriate interpretation of FDG PET/CT scans.</description><identifier>ISSN: 0363-9762</identifier><identifier>EISSN: 1536-0229</identifier><identifier>DOI: 10.1097/RLU.0b013e3182443e32</identifier><identifier>PMID: 22614189</identifier><language>eng</language><publisher>United States: Lippincott Williams &amp; Wilkins, Inc</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Female ; Fluorodeoxyglucose F18 ; Humans ; Male ; Middle Aged ; Multimodal Imaging ; Muscle Neoplasms - diagnostic imaging ; Muscle Neoplasms - secondary ; Muscle, Skeletal ; Positron-Emission Tomography ; Retrospective Studies ; Tomography, X-Ray Computed ; Whole Body Imaging ; Young Adult</subject><ispartof>Clinical nuclear medicine, 2012-06, Vol.37 (6), p.575-579</ispartof><rights>2012 Lippincott Williams &amp; Wilkins, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22614189$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Khandelwal, Alok R</creatorcontrib><creatorcontrib>Takalkar, Amol M</creatorcontrib><creatorcontrib>Lilien, David L</creatorcontrib><creatorcontrib>Ravi, Ajay</creatorcontrib><title>Skeletal Muscle Metastases on FDG PET/CT Imaging</title><title>Clinical nuclear medicine</title><addtitle>Clin Nucl Med</addtitle><description>BACKGROUNDSkeletal muscle metastases (SMM) are a rare occurrence despite the fact that skeletal muscle comprises more than 50% of total body mass. When present, most are asymptomatic and are often found incidentally on imaging. Several studies have reported isolated cases of patients with SMM. The goal of our study was to perform a comprehensive retrospective analysis of the incidence, frequency, and source of SMM in patients with malignancies who underwent whole-body FDG PET/CT imaging for the workup for their malignancy. METHODSThe records of 8492 consecutive patients referred for oncologic imaging at our institution during the period from January 2006 to December 2009 were reviewed. Patients who had SMM on FDG PET imaging were further assessed for collaborating evidence on other imaging modalities, pathology from tissue sampling, and follow-up scans. The incidence of SMM in our setting was calculated, and their association with various primary malignancies was also evaluated. RESULTSA total of 73 patients with SMM were identified on PET/CT imaging (incidence, 0.86%). Lung cancer was the most frequent source (25 patients [34%]), followed by gastrointestinal tract malignancies (13 patients [18%]), breast cancer (10 patients [14%]), genitourinary malignancies and lymphoma (6 patients [8%] each), melanoma (5 patients [7%]), and other miscellaneous malignancies (3 patients [4%]). Primary source remained unknown in only 5 patients (7%). Most patients with SMM generally had markedly widespread involvement which led to an unusual appearance on FDG PET/CT imaging. However, since most of these patients had stage IV malignant disease by virtue of visceral metastases elsewhere as well, they were generally not upstaged. CONCLUSIONSOur study confirmed the rare occurrence of SMM. Furthermore, FDG PET/CT can potentially detect unsuspected SMM. Interestingly, in our patient population, lung cancer was found to be the most frequent malignancy metastasizing to the skeletal muscles. Knowledge about the presence and appearance of widespread SMM may aid in appropriate interpretation of FDG PET/CT scans.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Female</subject><subject>Fluorodeoxyglucose F18</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Multimodal Imaging</subject><subject>Muscle Neoplasms - diagnostic imaging</subject><subject>Muscle Neoplasms - secondary</subject><subject>Muscle, Skeletal</subject><subject>Positron-Emission Tomography</subject><subject>Retrospective Studies</subject><subject>Tomography, X-Ray Computed</subject><subject>Whole Body Imaging</subject><subject>Young Adult</subject><issn>0363-9762</issn><issn>1536-0229</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1j91LAkEUxYco0qz_IGIfe1m98-08hqkJSlH6vOzHHTVnXdvZRfrvndAuBw7n8OPCIeSRQp-C0YPP-aoPGVCOnA6ZEMHZFelSyVUMjJlr0gWueGy0Yh1y5_03AFVUiVvSYUxRQYemS-Brhw6b1EWL1ucOo0UIPgh9VO2jyes0-hgvB6NlNCvT9Xa_vic3NnUeHy7eI6vJeDl6i-fv09noZR4fmFQ6FtwWgBptbjMLGUNpmeSCKWMKa6REkedaFBRBCkyzYQEB4lrmYItMWcV75Pn891BXPy36Jim3Pkfn0j1WrU8oUCmUEEYH9OmCtlmJRXKot2Va_yb_KwMgzsCxcg3WfufaI9bJBlPXbBIIx0GzmAFloEKK_yrNT5ygYvs</recordid><startdate>201206</startdate><enddate>201206</enddate><creator>Khandelwal, Alok R</creator><creator>Takalkar, Amol M</creator><creator>Lilien, David L</creator><creator>Ravi, Ajay</creator><general>Lippincott Williams &amp; Wilkins, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>201206</creationdate><title>Skeletal Muscle Metastases on FDG PET/CT Imaging</title><author>Khandelwal, Alok R ; Takalkar, Amol M ; Lilien, David L ; Ravi, Ajay</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p2567-43fd0e7efcfbf0b2e5f25342699df955e4cc74d1e054eab8d00b2375c0fdb6f63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Female</topic><topic>Fluorodeoxyglucose F18</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Multimodal Imaging</topic><topic>Muscle Neoplasms - diagnostic imaging</topic><topic>Muscle Neoplasms - secondary</topic><topic>Muscle, Skeletal</topic><topic>Positron-Emission Tomography</topic><topic>Retrospective Studies</topic><topic>Tomography, X-Ray Computed</topic><topic>Whole Body Imaging</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Khandelwal, Alok R</creatorcontrib><creatorcontrib>Takalkar, Amol M</creatorcontrib><creatorcontrib>Lilien, David L</creatorcontrib><creatorcontrib>Ravi, Ajay</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical nuclear medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Khandelwal, Alok R</au><au>Takalkar, Amol M</au><au>Lilien, David L</au><au>Ravi, Ajay</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Skeletal Muscle Metastases on FDG PET/CT Imaging</atitle><jtitle>Clinical nuclear medicine</jtitle><addtitle>Clin Nucl Med</addtitle><date>2012-06</date><risdate>2012</risdate><volume>37</volume><issue>6</issue><spage>575</spage><epage>579</epage><pages>575-579</pages><issn>0363-9762</issn><eissn>1536-0229</eissn><abstract>BACKGROUNDSkeletal muscle metastases (SMM) are a rare occurrence despite the fact that skeletal muscle comprises more than 50% of total body mass. When present, most are asymptomatic and are often found incidentally on imaging. Several studies have reported isolated cases of patients with SMM. The goal of our study was to perform a comprehensive retrospective analysis of the incidence, frequency, and source of SMM in patients with malignancies who underwent whole-body FDG PET/CT imaging for the workup for their malignancy. METHODSThe records of 8492 consecutive patients referred for oncologic imaging at our institution during the period from January 2006 to December 2009 were reviewed. Patients who had SMM on FDG PET imaging were further assessed for collaborating evidence on other imaging modalities, pathology from tissue sampling, and follow-up scans. The incidence of SMM in our setting was calculated, and their association with various primary malignancies was also evaluated. RESULTSA total of 73 patients with SMM were identified on PET/CT imaging (incidence, 0.86%). Lung cancer was the most frequent source (25 patients [34%]), followed by gastrointestinal tract malignancies (13 patients [18%]), breast cancer (10 patients [14%]), genitourinary malignancies and lymphoma (6 patients [8%] each), melanoma (5 patients [7%]), and other miscellaneous malignancies (3 patients [4%]). Primary source remained unknown in only 5 patients (7%). Most patients with SMM generally had markedly widespread involvement which led to an unusual appearance on FDG PET/CT imaging. However, since most of these patients had stage IV malignant disease by virtue of visceral metastases elsewhere as well, they were generally not upstaged. CONCLUSIONSOur study confirmed the rare occurrence of SMM. Furthermore, FDG PET/CT can potentially detect unsuspected SMM. Interestingly, in our patient population, lung cancer was found to be the most frequent malignancy metastasizing to the skeletal muscles. Knowledge about the presence and appearance of widespread SMM may aid in appropriate interpretation of FDG PET/CT scans.</abstract><cop>United States</cop><pub>Lippincott Williams &amp; Wilkins, Inc</pub><pmid>22614189</pmid><doi>10.1097/RLU.0b013e3182443e32</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0363-9762
ispartof Clinical nuclear medicine, 2012-06, Vol.37 (6), p.575-579
issn 0363-9762
1536-0229
language eng
recordid cdi_proquest_miscellaneous_1015464497
source MEDLINE; Journals@Ovid Complete
subjects Adult
Aged
Aged, 80 and over
Female
Fluorodeoxyglucose F18
Humans
Male
Middle Aged
Multimodal Imaging
Muscle Neoplasms - diagnostic imaging
Muscle Neoplasms - secondary
Muscle, Skeletal
Positron-Emission Tomography
Retrospective Studies
Tomography, X-Ray Computed
Whole Body Imaging
Young Adult
title Skeletal Muscle Metastases on FDG PET/CT Imaging
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T18%3A05%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Skeletal%20Muscle%20Metastases%20on%20FDG%20PET/CT%20Imaging&rft.jtitle=Clinical%20nuclear%20medicine&rft.au=Khandelwal,%20Alok%20R&rft.date=2012-06&rft.volume=37&rft.issue=6&rft.spage=575&rft.epage=579&rft.pages=575-579&rft.issn=0363-9762&rft.eissn=1536-0229&rft_id=info:doi/10.1097/RLU.0b013e3182443e32&rft_dat=%3Cproquest_pubme%3E1015464497%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1015464497&rft_id=info:pmid/22614189&rfr_iscdi=true